Forecasts data is unavailable for this security.
Consensus recommendation
- 18-May-23
- 15-Feb-24
- 14-Mar-24
- 18-Apr-24
- 03-May-24
Select bar for recommendation details.
Recommendations | 03-May-24 | |
---|---|---|
Buy | 1 | |
Outperform | 4 | |
Hold | 4 | |
Underperform | 0 | |
Sell | 0 |
Share price forecast
The 8 analysts offering 12 month price targets for Oxford BioMedica plc have a median target of 392.50, with a high estimate of 740.00 and a low estimate of 224.00. The median estimate represents a 30.83% increase from the last price of 300.00.
High | 146.7% | 740.00 |
Med | 30.8% | 392.50 |
Low | -25.3% | 224.00 |
Earnings history & estimates
Average growth rate | +9.53% |
More ▼
Revenue history & estimates
Average growth rate | +15.43% |
More ▼